PA(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) (BioCAD00000109158)

{$topic}

Metabolite Card

Formula: C41H71O8P (722.4886)
SMILES: [H][C@@](COC(=O)CCCCCCC\C=C/CCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC

Synonyms [en]

PA(18:1/20:4) ; PA(18:1n9/20:4n3) ; [(2R)-2-[(8Z,11Z,14Z,17Z)-Icosa-8,11,14,17-tetraenoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphonate; Phosphatidic acid(18:1n9/20:4n3) ; PA(38:5) ; Phosphatidate(18:1/20:4)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

PA(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000109158). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

PA(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Entity Information

DBLinks

  • CAS Registry Number:
  • PubChem CID: 131821930
  • ChEBI:
  • HMDB: HMDB0114935
  • LipidMaps:
  • KEGG:
  • BioCyc:
  • NCBI MeSH:
  • Wikipedia:
Other DBLinks
  • PubChem: 131821930
  • HMDB: HMDB0114935

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0066560 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0066564 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PathBank:SMP0066568 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0075316 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:0)
PathBank:SMP0075320 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0075324 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
PathBank:SMP0085029 Cardiolipin Biosynthesis CL(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0086181 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0090585 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0090589 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PathBank:SMP0090593 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0022499 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
PathBank:SMP0022503 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
PathBank:SMP0022507 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0022511 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0099542 Cardiolipin Biosynthesis CL(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:0/22:0)
PathBank:SMP0066563 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PathBank:SMP0066567 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0033201 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))
PathBank:SMP0075315 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
View All Pathways